4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001578563-19-000034
Chief Commercial Officer acquired 512,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Phillips Matthew V · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-08-23 | Grant or award : show line 1 in the form | +512,500 | $1.07 | $548,375 | 512,500 | I |
Loading xslF345X03/primary_doc.xml…